Physician Opinions About “Fair” Prices Vary for Certain Therapies
As the cost of pharmaceutical and biotechnology therapies continues to rise, concern about the ...
Moving Toward an Agile KAM Future
Physical access has been a growing challenge in life sciences as the number of ...
The Rush to Real-Time ROI: Pharma’s Quest for Conversions in a New COVID Reality
As the head of a data marketing and healthcare IT company, I’m no stranger ...
Survey of NPs and PAs Reveal How Pharma Can Offer More Support During COVID
For many nurse practitioners (NPs) and physician assistants (PAs), the COVID-19 pandemic led to ...
- 2020
- Clinical Trials
- Commercialization
- Feature Articles
- HCPs
- July/August
- Marketing Strategy
- Medical Affairs
Working with Your Medical Affairs Team to Expedite Approval
As a marketer, it stands to reason you are keenly aware of the role ...
Launching a Practice Virtually During COVID-19
I was in the final stages of opening my new women’s wellness clinic when ...
A Nimble Social Strategy a Must for Reopening Physician Practices
As all organizations try to adapt to doing business in the COVID environment, it ...
Survey Reveals Most Effective Digital Engagement Strategies for our New Normal
With many industry conferences, events, and in-person meetings stalled for another 12 to 18 ...
Despite COVID-19, The Doctor is Still In
While pharma sales rep access has been shut down, the vast majority of physician ...
Considering AI? 3 Ways to Set Your Commercial Team Up for Success
Artificial Intelligence (AI) is rapidly becoming pervasive in enterprise applications and embedded within specific ...
What Physicians Want in the Post-COVID-19 Era
The COVID-19 pandemic is driving profound changes to U.S. healthcare delivery systems—changes that are ...
Advanced Practice Providers Replacing Physicians
In 2020, one out of every three U.S. providers are nurse practitioners (NPs) or ...
Skeptical HCPs—How to Win Them Over
The relationship between pharmaceutical brands and HCPs has long been marked by skepticism and ...
